These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23885544)

  • 1. [Enantiomers: a new problem in pharmacotherapy of depression?].
    Grodner B; Sitkiewicz D
    Psychiatr Pol; 2013; 47(3):511-8. PubMed ID: 23885544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram.
    Baumann P; Zullino DF; Eap CB
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):433-44. PubMed ID: 12208561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSRI-TCA combination in the treatment of resistant depression.
    Terao T; Ikemura N
    J Clin Psychiatry; 2000 Jul; 61(7):529. PubMed ID: 10937615
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus.
    Poggini S; Golia MT; Alboni S; Milior G; Sciarria LP; Viglione A; Matte Bon G; Brunello N; Puglisi-Allegra S; Limatola C; Maggi L; Branchi I
    Neural Plast; 2019; 2019():4651031. PubMed ID: 30804991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective serotonin reuptake inhibitors--current knowledge].
    Dudek D; Zieba A; Siwek M; Wróbel A
    Psychiatr Pol; 2004; 38(3):507-24. PubMed ID: 15199659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine: new indication. Depression in children: too many uncertainties.
    Prescrire Int; 2008 Oct; 17(97):186-7. PubMed ID: 19534039
    [No Abstract]   [Full Text] [Related]  

  • 9. Care of depression in the elderly: comparative pharmacokinetics of SSRIs.
    Baumann P
    Int Clin Psychopharmacol; 1998 Sep; 13 Suppl 5():S35-43. PubMed ID: 9817619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational stress and fluoxetine treatment differentially affect plasticity, methylation and serotonin levels in the PFC and hippocampus of rat dams.
    Gemmel M; Rayen I; van Donkelaar E; Loftus T; Steinbusch HW; Kokras N; Dalla C; Pawluski JL
    Neuroscience; 2016 Jul; 327():32-43. PubMed ID: 27060483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major depression: its recognition and treatment. Part 2. Second-generation and newer antidepressants.
    Cohen LJ; Grothe DR
    Am Pharm; 1992 Nov; NS32(11):44-9. PubMed ID: 1442541
    [No Abstract]   [Full Text] [Related]  

  • 13. Agomelatine: new drug. Adverse effects and no proven efficacy.
    Prescrire Int; 2009 Dec; 18(104):241-5. PubMed ID: 20020562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug treatment of depression in children and adolescents].
    Grøholt B
    Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2243-5. PubMed ID: 22085951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of antidepressants: why and how they are relevant to treatment.
    Preskorn SH
    J Clin Psychiatry; 1993 Sep; 54 Suppl():14-34; discussion 55-6. PubMed ID: 8407856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pain on depression treatment response in primary care.
    Bair MJ; Robinson RL; Eckert GJ; Stang PE; Croghan TW; Kroenke K
    Psychosom Med; 2004; 66(1):17-22. PubMed ID: 14747633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology.
    Nutt DJ; Feetam CL
    J Psychopharmacol; 2010 Aug; 24(8):1137-41. PubMed ID: 20663810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practitioner review: the pharmacotherapy of adolescent depression.
    Kutcher S
    J Child Psychol Psychiatry; 1997 Oct; 38(7):755-67. PubMed ID: 9363575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.
    Preskorn SH; Alderman J; Chung M; Harrison W; Messig M; Harris S
    J Clin Psychopharmacol; 1994 Apr; 14(2):90-8. PubMed ID: 8195463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological principles of antidepressant efficacy.
    Schatzberg AF
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.